|
|
|
Insider
Information: |
Bradbury Daniel |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
232,105 |
|
Indirect Shares
|
3,161,475 |
|
|
Direct
Value |
$2,471,016 |
|
|
Indirect Value
|
$4,283,565 |
|
|
Total
Shares |
3,393,580 |
|
|
Total
Value |
$6,754,581 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Amylin Pharmaceuticals Inc |
AMLN |
President & Chief Exec... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
Director |
2006-05-09 |
35,714 |
|
0 |
Premium* |
|
Illumina Inc |
ILMN |
Director |
2017-05-25 |
15,324 |
2008-05-16 |
0 |
Premium* |
|
Corcept Therapeutics Inc |
CORT |
Director |
2012-11-21 |
0 |
2019-02-07 |
130,575 |
Premium* |
|
Geron Corporation |
GERN |
Director |
2014-05-09 |
142,776 |
2019-03-29 |
51,323 |
Premium* |
|
Equillium Inc |
EQ |
Chief Executive Office... |
2018-10-16 |
0 |
2018-10-16 |
2,969,596 |
Premium* |
|
Castle Biosciences Inc |
CSTL |
Director |
2024-05-25 |
13,291 |
2024-05-06 |
9,981 |
Premium* |
|
Nuvation Bio Ord Shs Class A |
NUVB |
Director |
2021-02-10 |
25,000 |
2021-02-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
424 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 17
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-09-08 |
4/A |
AS |
$44.25 |
$106,687 |
I/I |
(2,411) |
10,996 |
0 |
- |
|
CSTL |
Castle Biosciences Inc |
Director |
|
2022-01-18 |
4 |
AS |
$35.07 |
$87,201 |
I/I |
(2,470) |
125,651 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2006-12-07 |
4 |
AS |
$39.35 |
$98,369 |
I/I |
(2,500) |
2,496 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2007-01-09 |
4 |
AS |
$38.51 |
$96,276 |
I/I |
(2,500) |
11,394 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2007-03-07 |
4 |
AS |
$37.00 |
$92,500 |
I/I |
(2,500) |
5,394 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-04-09 |
4 |
AS |
$38.66 |
$96,657 |
I/I |
(2,500) |
1,597 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2013-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
11,150 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2014-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,542 |
12,466 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2012-05-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,548 |
86,197 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2009-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,550 |
3,455 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2016-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,853 |
16,465 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Exec Officer |
|
2007-05-07 |
4 |
AS |
$41.90 |
$121,259 |
I/I |
(2,894) |
37,972 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-04-07 |
4 |
AS |
$46.10 |
$138,301 |
I/I |
(3,000) |
25,907 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-05-05 |
4 |
AS |
$43.30 |
$129,900 |
I/I |
(3,000) |
22,907 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-06-07 |
4 |
AS |
$44.45 |
$135,180 |
I/I |
(3,000) |
19,907 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Chief Operating Officer |
|
2006-08-07 |
4 |
AS |
$47.41 |
$142,230 |
I/I |
(3,000) |
13,407 |
|
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2006-10-06 |
4 |
AS |
$42.50 |
$127,500 |
I/I |
(3,000) |
7,996 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Operating |
|
2006-11-07 |
4 |
AS |
$44.51 |
$133,537 |
I/I |
(3,000) |
4,996 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2008-06-18 |
4 |
OE |
$8.07 |
$24,210 |
D/D |
3,000 |
4,000 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2008-06-18 |
4 |
AS |
$81.67 |
$245,019 |
D/D |
(3,000) |
1,000 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2008-07-23 |
4 |
AS |
$90.95 |
$272,838 |
D/D |
(3,000) |
1,000 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2008-07-23 |
4 |
OE |
$8.07 |
$24,210 |
D/D |
3,000 |
4,000 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2008-08-19 |
4 |
AS |
$91.24 |
$276,728 |
D/D |
(3,000) |
1,000 |
0 |
- |
|
ILMN |
Illumina Inc |
Director |
|
2008-08-19 |
4 |
OE |
$8.07 |
$24,210 |
D/D |
3,000 |
1,400 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
President & Chief Executive Of |
|
2010-02-26 |
5 |
GA |
$0.00 |
$0 |
I/I |
3,028 |
16,185 |
0 |
- |
|
424 Records found
|
|
Page 8 of 17 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|